Metraipolis › archive › dc_db7712f908fa

Immunotherapy in Thyroid Cancer: Current Strategies and Challenges — Europe PMC PMID:41992056

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41992056
DOI
10.1002/cam4.71742
License (as archived)
solo-consultazione
Archived
2026-11-03T12:49:40.774Z
SHA-256 of the archived text
fa504316799fbaf5faa589cf0d0d7718bf36c59d979e5c6ce7a63c00a4674117
Stable URL of this page
https://metraipolis.com/documento/dc_db7712f908fa

How to cite

Immunotherapy in Thyroid Cancer: Current Strategies and Challenges — Europe PMC PMID:41992056 — Europe PMC (en), https://europepmc.org/article/MED/41992056 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_db7712f908fa (Metraipolis archive dc_db7712f908fa, sha256 fa504316799fbaf5faa589cf0d0d7718bf36c59d979e5c6ce7a63c00a4674117)
BibTeX
@misc{dcdb7712f908fa,
  title = {Immunotherapy in Thyroid Cancer: Current Strategies and Challenges — Europe PMC PMID:41992056},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41992056},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_db7712f908fa; sha256 fa504316799fbaf5faa589cf0d0d7718bf36c59d979e5c6ce7a63c00a4674117},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41992056. Agents can read the archived copy with the MCP tool read_document.